Melphalan-induced apoptosis of EBV-transformed B cells through upregulation of TAp73 and XAF1 and nuclear import of XPA

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 6281-6291

  Park, Ga Bin ^a   Kim, Yeong Seok ^a   Kim, Daejin ^a   Kim, Seonghan ^a   Lee, Hyun Kyung ^b   Cho, Dae Ho ^c   Lee, Wang Jae ^d   Hur, Dae Young ^a  

^a Inje University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 2,4 PYRROLIDINE DICARBOXYLIC ACID; CASPASE 3; CASPASE 9; MELPHALAN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN P73; PUMA PROTEIN; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR; TRANSCRIPTIONALLY ACTIVE PROTEIN P73; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; X LINKED INHIBITOR OF APOPTOSIS PROTEIN ASSOCIATED FACTOR 1; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BCONTROLLED STUDY; BNONHUMAN; CYTOSOL; CYTOTOXICITY; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; MITOCHONDRIAL MEMBRANE; NUCLEAR IMPORT; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS CELL TRANSFORMATION;

EID: 84890399178     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203442     Document Type: Article

References (40)

1. Wang, W., S. H. Kim, and W. S. El-Deiry. 2006. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts. Proc. Natl. Acad. Sci. USA 103: 11003-11008.
2. Shimodaira, H., A. Yoshioka-Yamashita, R. D. Kolodner, and J. Y. Wang. 2003. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. USA 100: 2420-2425.
3. Irwin, M. S., and W. G. Kaelin. 2001. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ. 12: 337-349.
4. Melino, G., F. Bernassola, M. Ranalli, K. Yee, W. X. Zong, M. Corazzari, R. A. Knight, D. R. Green, C. Thompson, and K. H. Vousden. 2004. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J. Biol. Chem. 279: 8076-8083.
5. Gonzalez, S., C. Prives, and C. Cordon-Cardo. 2003. p73alpha regulation by Chk1 in response to DNA damage. Mol. Cell. Biol. 23: 8161-8171.
6. Yuan, Z. M., H. Shioya, T. Ishiko, X. Sun, J. Gu, Y. Y. Huang, H. Lu, S. Kharbanda, R. Weichselbaum, and D. Kufe. 1999. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399: 814-817.
7. Wang, P., W. Yu, Z. Hu, L. Jia, V. R. Iyer, B. G. Sanders, and K. Kline. 2008. Involvement of JNK/p73/NOXA in vitamin E analog-induced apoptosis of human breast cancer cells. Mol. Carcinog. 47: 436-445.
8. Sanchez-Prieto, R., V. J. Sanchez-Arevalo, J. M. Servitja, and J. S. Gutkind. 2002. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene 21: 974-979.
9. Ramadan, S., A. Terrinoni, M. V. Catani, A. E. Sayan, R. A. Knight, M. Mueller, P. H. Krammer, G. Melino, and E. Candi. 2005. p73 induces apoptosis by different mechanisms. Biochem. Biophys. Res. Commun. 331: 713-717.
10. Liston, P., W. G. Fong, N. L. Kelly, S. Toji, T. Miyazaki, D. Conte, K. Tamai, C. G. Craig, M. W. McBurney, and R. G. Korneluk. 2001. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat. Cell Biol. 3: 128-133.
11. Wang, J., H. He, L. Yu, H. H. Xia, M. C. Lin, Q. Gu, M. Li, B. Zou, X. An, B. Jiang, et al. 2006. HSF1 down-regulates XAF1 through transcriptional regulation. J. Biol. Chem. 281: 2451-2459.
12. Tu, S. P., Y. W. Sun, J. T. Cui, B. Zou, M. C. Lin, Q. Gu, S. H. Jiang, H. F. Kung, R. G. Korneluk, and B. C. Wong. 2010. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression. Cancer 116: 1252-1263.
13. Byun, D. S., K. Cho, B. K. Ryu, M. G. Lee, M. J. Kang, H. R. Kim, and S. G. Chi. 2003. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res. 63: 7068-7075.
14. Lee, M. G., J. S. Huh, S. K. Chung, J. H. Lee, D. S. Byun, B. K. Ryu, M. J. Kang, K. S. Chae, S. J. Lee, C. H. Lee, et al. 2006. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses. Oncogene 25: 5807-5822.
15. Huang, J., W. Y. Yao, Q. Zhu, S. P. Tu, F. Yuan, H. F. Wang, Y. P. Zhang, and Y. Z. Yuan. 2010. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer. Cancer Sci. 101: 559-567.
16. Fong, W. G., P. Liston, E. Rajcan-Separovic, M. St Jean, C. Craig, and R. G. Korneluk. 2000. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 70: 113-122.
17. Straszewski-Chavez, S. L., I. P. Visintin, N. Karassina, G. Los, P. Liston, R. Halaban, A. Fadiel, and G. Mor. 2007. XAF1 mediates tumor necrosis factor-alpha-induced apoptosis and X-linked inhibitor of apoptosis cleavage by acting through the mitochondrial pathway. J. Biol. Chem. 282: 13059-13072.
18. Rothbarth, J., C. Koevoets, R. A. Tollenaar, M. J. Tilby, C. J. van de Velde, G. J. Mulder, and P. J. Kuppen. 2004. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo. Biochem. Pharmacol. 67: 1771-1778.
19. Sancar, A., L. A. Lindsey-Boltz, K. Unsal-Kaçmaz, and S. Linn. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73: 39-85.
20. Küppers, R. 2003. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3: 801-812.
21. Rosenkranz, A. R., S. Schmaldienst, K. M. Stuhlmeier, W. Chen, W. Knapp, and G. J. Zlabinger. 1992. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate. J. Immunol. Methods 156: 39-45.
22. Burnette, W. N. 2009. Western blotting : remembrance of past things. Methods Mol. Biol. 536: 5-8.
23. Susnow, N., L. Zeng, D. Margineantu, and D. M. Hockenbery. 2009. Bcl-2 family proteins as regulators of oxidative stress. Semin. Cancer Biol. 19: 42-49.
24. Al-Bahlani, S., M. Fraser, A. Y. Wong, B. S. Sayan, R. Bergeron, G. Melino, and B. K. Tsang. 2011. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene 30: 4219-4230.
25. Zhang, P., S. S. Liu, and H. Y. Ngan. 2012. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells. PLoS ONE 7: e42985.
26. Müller, M., T. Schilling, A. E. Sayan, A. Kairat, K. Lorenz, H. Schulze-Bergkamen, M. Oren, A. Koch, A. Tannapfel, W. Stremmel, et al. 2005. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ. 12: 1564-1577.
27. Ibrahim, N., L. He, C. O. Leong, D. Xing, B. Y. Karlan, E. M. Swisher, B. R. Rueda, S. Orsulic, and L. W. Ellisen. 2010. BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma. Cancer Res. 70: 7155-7165.
28. Zhu, J., S. Nozell, J. Wang, J. Jiang, W. Zhou, and X. Chen. 2001. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 20: 4050-4057.
29. Dicker, F., A. P. Kater, C. E. Prada, T. Fukuda, J. E. Castro, G. Sun, J. Y. Wang, and T. J. Kipps. 2006. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53. Blood 108: 3450-3457.
30. Dar, A. A., A. Belkhiri, J. Ecsedy, A. Zaika, and W. El-Rifai. 2008. Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells. Cancer Res. 68: 8998-9004.
31. Vayssade, M., H. Haddada, L. Faridoni-Laurens, S. Tourpin, A. Valent, J. Bénard, and J. C. Ahomadegbe. 2005. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int. J. Cancer 116: 860-869.
32. Circu, M. L., and T. Y. Aw. 2010. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 48: 749-762.
33. Dhillon, A. S., S. Hagan, O. Rath, and W. Kolch. 2007. MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290.
34. Ravindran, J., N. Gupta, M. Agrawal, A. S. Bala Bhaskar, and P. V. Lakshmana Rao. 2011. Modulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via, mitochondrial mediated caspase-dependent mechanism. Apoptosis 16: 145-161.
35. Liu, J. H., C. C. Liu, C. C. Yen, J. P. Gau, W. S. Wang, and C. H. Tzeng. 2009. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells. Int. J. Cancer 125: 71-77.
36. Wang, J., W. Zhang, Y. Zhang, Y. Chen, B. Zou, B. Jiang, R. Pang, Q. Gu, L. Qiao, H. Lan, et al. 2009. c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer. Carcinogenesis 30: 222-229.
37. Ming, L., P. Wang, A. Bank, J. Yu, and L. Zhang. 2006. PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J. Biol. Chem. 281: 16034-16042.
38. Wu, X., S. M. Shell, Y. Liu, and Y. Zou. 2007. ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation. Oncogene 26: 757-764.
39. Im, J. S., and J. K. Lee. 2008. ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7. J. Biol. Chem. 283: 25171-25177.
40. Zhu, K. Q., and S. J. Zhang. 2003. Involvement of ATM/ATR-p38 MAPK cascade in MNNG induced G1-S arrest. World J. Gastroenterol. 9: 2073-2077.